9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Patterns of Weakness, Classification of Motor Neuron Disease & Clinical Diagnosis of Sporadic ALS

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Synopsis

          When approaching the patient with suspected motor neuron disease (MND) the pattern of weakness on exam helps distinguish MND from other diseases of peripheral nerves, the neuromuscular junction, or muscle. MND is a clinical diagnosis supported by findings on electrodiagnostic testing, in the absence of other abnormalities on neuroimaging or serological testing. MNDs exist on a spectrum: from a pure lower motor neuron; to mixed upper and lower motor neuron; to a pure upper motor neuron variant in addition to regional variants restricted to the arms, legs or bulbar region. Amyotrophic lateral sclerosis (ALS) is a progressive mixed upper and lower motor neuron disorder, most commonly sporadic (~85%), which is invariably fatal. The only FDA approved treatments for ALS are riluzole, which prolongs life by about 3 months, and dextromethorphan/quinidine which provides symptomatic relief for pseudobulbar affect (inappropriate bouts of laughter or crying). Here we describe a pattern approach to identifying motor neuron disease, and clinical features of sporadic ALS.

          Related collections

          Author and article information

          Journal
          8219232
          5883
          Neurol Clin
          Neurol Clin
          Neurologic clinics
          0733-8619
          1557-9875
          23 July 2015
          08 September 2015
          November 2015
          01 November 2016
          : 33
          : 4
          : 735-748
          Affiliations
          "> [1 ] Department of Neurology, University of Kansas Medical Center, Kansas City, KS
          [2 ] California Pacific Medical Center, San Francisco, CA
          Author notes

          Author Contact Information:

          April L. McVey, MD amcvey@ 123456kumc.edu

          Richard Barohn, MD, rbarohn@ 123456kumc.edu

          Mazen Dimachkie, MD, mdimachkie@ 123456kumc.edu

          University of Kansas Medical Center, Dept. of Neurology 3901 Rainbow Blvd, Mailstop 2012 Kansas City, KS 66160

          Jonathan Katz, MD, KatzJS@ 123456cpmcri.org

          475 Brannan Street, Suite 220 San Francisco, CA 94107

          Corresponding author: Jeffrey Statland, MD, jstatland@ 123456kumc.edu
          Article
          PMC4629510 PMC4629510 4629510 nihpa707578
          10.1016/j.ncl.2015.07.006
          4629510
          26515618
          e12f16f0-0f0f-44c2-87bc-ea9165596f8f
          History
          Categories
          Article

          Lower motor neuron,Amyotrophic lateral sclerosis,Lou Gehrig's disease,Motor neuron disease,Upper motor neuron

          Comments

          Comment on this article